Treo Ventures (formerly known as Strategic Healthcare Investment Partners-S.H.I.P.), a venture capital fund focused on investments in high impact companies at the intersection of biology and technology in  medical devices and digital health, announced the successful closing of its $128 million debut fund.  The fund has a presence in Silicon Valley, CA and Dublin, Ireland, and will be supporting world class entrepreneurs across these geographies. Treo has been actively investing and building a portfolio of category defining companies including Hyalex Orthopedics, CVRx, ShiraTronics, Intuity Medical, NeoChord, and Noctrix Health.